AAPL   323.68 (+0.11%)
MSFT   184.30 (-0.33%)
NVDA   349.74 (-0.93%)
MU   48.24 (+3.03%)
TSLA   888.78 (+0.82%)
T   31.58 (+1.90%)
ACB   14.35 (-1.24%)
GILD   74.14 (+1.20%)
DIS   121.90 (+2.64%)
NFLX   420.26 (-1.65%)
BAC   26.04 (+4.83%)
BA   166.15 (+8.38%)
AAPL   323.68 (+0.11%)
MSFT   184.30 (-0.33%)
NVDA   349.74 (-0.93%)
MU   48.24 (+3.03%)
TSLA   888.78 (+0.82%)
T   31.58 (+1.90%)
ACB   14.35 (-1.24%)
GILD   74.14 (+1.20%)
DIS   121.90 (+2.64%)
NFLX   420.26 (-1.65%)
BAC   26.04 (+4.83%)
BA   166.15 (+8.38%)
AAPL   323.68 (+0.11%)
MSFT   184.30 (-0.33%)
NVDA   349.74 (-0.93%)
MU   48.24 (+3.03%)
TSLA   888.78 (+0.82%)
T   31.58 (+1.90%)
ACB   14.35 (-1.24%)
GILD   74.14 (+1.20%)
DIS   121.90 (+2.64%)
NFLX   420.26 (-1.65%)
BAC   26.04 (+4.83%)
BA   166.15 (+8.38%)
AAPL   323.68 (+0.11%)
MSFT   184.30 (-0.33%)
NVDA   349.74 (-0.93%)
MU   48.24 (+3.03%)
TSLA   888.78 (+0.82%)
T   31.58 (+1.90%)
ACB   14.35 (-1.24%)
GILD   74.14 (+1.20%)
DIS   121.90 (+2.64%)
NFLX   420.26 (-1.65%)
BAC   26.04 (+4.83%)
BA   166.15 (+8.38%)
Log in

TSE:HEXOHexo Stock Price, Forecast & News

C$0.91
+0.03 (+3.41 %)
(As of 06/3/2020 12:50 PM ET)
Add
Compare
Today's Range
C$0.89
Now: C$0.91
C$0.94
50-Day Range
C$0.62
MA: C$0.75
C$1.09
52-Week Range
C$0.50
Now: C$0.91
C$9.02
Volume3.57 million shs
Average Volume4.02 million shs
Market CapitalizationC$371.15 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
HEXO Corp., through its subsidiary, HEXO Operations Inc., produces, markets, and sells cannabis in Canada. The company offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. It provides its products under the HEXO and Hydropothecary brand names. The company serves medical and adult-use markets. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. is headquartered in Gatineau, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.9Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.31 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone844-406-1852

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$59.95 million
Cash FlowC$0.26 per share
Book ValueC$1.83 per share

Profitability

Miscellaneous

Employees374
Market CapC$371.15 million
Next Earnings DateN/A
OptionableOptionable

Receive HEXO News and Ratings via Email

Sign-up to receive the latest news and ratings for HEXO and its competitors with MarketBeat's FREE daily newsletter.

Hexo (TSE:HEXO) Frequently Asked Questions

How has Hexo's stock been impacted by COVID-19 (Coronavirus)?

Hexo's stock was trading at C$1.27 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, HEXO stock has decreased by 28.3% and is now trading at C$0.91. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Hexo?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hexo in the last year. There are currently 1 sell rating and 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Hexo.

What price target have analysts set for HEXO?

4 brokers have issued twelve-month price targets for Hexo's shares. Their forecasts range from C$0.75 to C$2.00. On average, they anticipate Hexo's share price to reach C$1.37 in the next year. This suggests a possible upside of 50.7% from the stock's current price. View analysts' price targets for Hexo.

Has Hexo been receiving favorable news coverage?

Press coverage about HEXO stock has trended somewhat positive on Wednesday, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Hexo earned a daily sentiment score of 1.7 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the company's share price in the near future. View the latest news aboutHexo.

Who are some of Hexo's key competitors?

What other stocks do shareholders of Hexo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hexo investors own include Aurora Cannabis (ACB), Aurora Cannabis (ACB), Canopy Growth (CGC), Canopy Growth (WEED), Aphria (APHA), Green Organic Dutchman (TGOD), Curaleaf (CURLF), Tilray (TLRY), Charlotte's Web (CWBHF) and KushCo (KSHB).

Who are Hexo's key executives?

Hexo's management team includes the following people:
  • Mr. Sebastien G. St-Louis, Co-Founder, Pres, CEO & Director (Age 35)
  • Mr. Adam Miron, Co-founder, Chief Brand Officer & Director (Age 35)
  • Mr. Ed Chaplin, CFO & Corp. Sec. (Age 49)
  • Mr. James McMillan, VP of Bus. Devel. (Age 51)
  • Dr. Terence Lake DVM, Vice-Pres of Corp. & Social Responsibility

What is Hexo's stock symbol?

Hexo trades on the Toronto Stock Exchange (TSX) under the ticker symbol "HEXO."

How do I buy shares of Hexo?

Shares of HEXO and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Hexo's stock price today?

One share of HEXO stock can currently be purchased for approximately C$0.91.

How big of a company is Hexo?

Hexo has a market capitalization of C$371.15 million and generates C$59.95 million in revenue each year. Hexo employs 374 workers across the globe.

What is Hexo's official website?

The official website for Hexo is hexo.com.

How can I contact Hexo?

The company can be reached via phone at 844-406-1852.

This page was last updated on 6/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.